Nanoparticles Targeting STATs in Cancer Therapy

Abstract

Over the past decades, an increase in the incidence rate of cancer has been witnessed. Although many efforts have been made to manage and treat this life threatening condition, it is still one of the leading causes of death worldwide. Therefore, scientists have attempted to target molecular signaling pathways involved in cancer initiation and metastasis. It has been shown that signal transducers and activator of transcription (STAT) contributes to the progression of cancer cells. This important signaling pathway is associated with a number of biological processes including cell cycle, differentiation, proliferation and apoptosis. It appears that dysregulation of the STAT signaling pathway promotes the migration, viability and malignancy of various tumor cells. Hence, there have been many attempts to target the STAT signaling pathway. However, it seems that currently applied therapeutics may not be able to effectively modulate the STAT signaling pathway and suffer from a variety of drawbacks such as low bioavailability and lack of specific tumor targeting. In the present review, we demonstrate how nanocarriers can be successfully applied for encapsulation of STAT modulators in cancer therapy.

Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics

“…Completed correction of the memory defect in an experimental model of AD [139] PLGA functionalized with OX26-type monoclonal antibody TMZ Cytotoxicity improvement of TMZ [140] PLGA-b-PEG-ascorbic acid Galantamine (GLM) High biodistribution, therapeutic, and sustained action of the drug [141] [44,[163][164][165][166][167][168][169][170][171][172]. Among them, polyesters have great potential because of their biocompatibility and biodegradability.…”

“…Synthetic polymers have been widely used for the delivery of bioactive agents and drugs [44,[163][164][165][166][167][168][169][170][171][172]. Among them, polyesters have great potential because of their biocompatibility and biodegradability.…”

Functionalization of Polymers and Nanomaterials for Biomedical Applications: Antimicrobial Platforms and Drug Carriers

“…Anticancer drugs possessing off-target toxicity showed several disadvantages [76]. Thus, tumortargeted drug delivery mediated by nanoparticles is a promising strategy to fight cancer [77][78][79]. Particles can be modified with specific ligands expressing high affinity for their complementary receptor on the cell's surface.…”

MicroRNAs as novel targets of sulforaphane in cancer therapy: The beginning of a new tale?

“…So, there is a need for developing new anticancer drugs to be used with conventional and newly introduced anticancer drugs for targeting multiple signaling pathways and making a reduction in the viability of cancer cells. It seems that plant‐derived chemicals with high antitumor activity are of interest due to their minimal side effects and multitargeting (Ashrafizadeh, Ahmadi, Farkhondeh, & Samarghandian, ; Ashrafizadeh et al, ; Ashrafizadeh et al, ; Khoshakhlagh et al, ; Soleimani et al, ; Soleimani et al, ; Tavakol et al, ).…”